Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Surg Oncol. 2016 Jan 22;113(5):496–500. doi: 10.1002/jso.24184

Table 4.

Age- and year-adjusted odds ratios for adverse tumor characteristics according to screening participation (1996-2012). AGES 40-49

Odds Ratios* (95% Confidence Interval)
Screened Non-Screened P-value
Invasive (vs. in situ) 1.00 (Ref) 4.85 (3.40, 6.91) <0.0001
Late stage 1.00 (Ref) 2.77 (2.20, 3.48) <0.0001
Large size 1.00 (Ref) 3.70 (2.90, 4.73) <0.0001
High grade (vs. low/intermediate) 1.00 (Ref) 1.33 (1.04-1.69) 0.02
ER negative 1.00 (Ref) 1.50 (1.11, 2.03) 0.01
Any nodes removed 1.00 (Ref) 1.89 (1.44, 2.48) <0.0001
Regional nodes removed 1.00 (Ref) 1.94 (1.54-2.44) <0.0001
Nodes positive 1.00 (Ref) 2.48 (1.97, 3.13) <0.0001
Mastectomy 1.00 (Ref) 1.28 (1.00, 1.62) 0.05
*

All analysis adjusted for year and age